BioSpace News Archive

Business

Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation

Provectus Biopharmaceuticals, Inc. today announced additions to its executive leadership team, reflecting Provectus’s dedication to enhancing shareholder value.

April 16, 2024
·
6 min read
Pharm Country

Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development

Chimeron Bio, a Philadelphia -headquartered biotech company, has received a 2024 National Institutes of Health’s Small Business Innovation Research Innovative Concept Award through the National Cancer Institute.

April 16, 2024
·
1 min read
Business

BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients

BostonGene and Saga University announced today the launch of a collaboration aimed at at discovering biomarkers for immunotherapy (IO) treatment response and treatment-related toxicity in advanced non-small cell lung cancer (NSCLC) patients.

April 16, 2024
·
3 min read
Business

PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance

PacBio today announced preliminary, unaudited revenue for the quarter ended March 31, 2024.

April 16, 2024
·
12 min read
Drug Development

Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced final results from the HD cohort of the Phase 4 START study, demonstrating positive real-world effectiveness, safety, adherence and satisfaction with the 4-week Titration Kit for AUSTEDO.

April 16, 2024
·
11 min read
Genetown

Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing.

April 16, 2024
·
5 min read
IRLAB to Present at Redeye Investor Forum - April 16, 2024

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present at Redeye Investor Forum on April 18.

April 16, 2024
·
1 min read
Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced , ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases, that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.

April 16, 2024
·
4 min read
Business

Spago Nanomedical Strengthens Management with Head of CMC & Supply

Spago Nanomedical Spago Nanomedical AB announced the appointment of Birgitta Rembratt Svensson as Head of CMC & Supply.

April 16, 2024
·
1 min read
Business

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline

Boehringer Ingelheim announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as planned.

April 16, 2024
·
6 min read